嘉應制藥(002198)3月(yue)13日晚間公告(gao),公司控(kong)股(gu)股(gu)東(dong)黃小(xiao)彪于2014年(nian)6月(yue)至(zhi)2015年(nian)3月(yue)期(qi)間通過(guo)深圳證券交易(yi)所大宗交易(yi)系統和(he)二(er)級市場(chang)競(jing)價累計(ji)轉(zhuan)讓公司股(gu)份2527.31萬股(gu),其持股(gu)比例由(you)18.27%下(xia)降(jiang)至(zhi)13.29%。
嘉(jia)應制藥表(biao)示,黃小彪(biao)減持公(gong)(gong)司(si)(si)股(gu)(gu)份是出于個人(ren)理財需(xu)求的資金規劃。本(ben)次減持后,黃小彪(biao)持有(you)(you)公(gong)(gong)司(si)(si)股(gu)(gu)份6746.57萬股(gu)(gu),占公(gong)(gong)司(si)(si)總股(gu)(gu)本(ben)的13.29%。第二大股(gu)(gu)東(dong)(dong)陳泳洪持有(you)(you)公(gong)(gong)司(si)(si)股(gu)(gu)份5554.1萬股(gu)(gu),占公(gong)(gong)司(si)(si)總股(gu)(gu)本(ben)的10.94%。黃小彪(biao)仍為公(gong)(gong)司(si)(si)控股(gu)(gu)股(gu)(gu)東(dong)(dong)。